Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $209,657 | $198,149 | $225,844 | $252,779 |
| - Cash | $18,169 | $8,007 | $8,629 | $13,242 |
| + Debt | $41,374 | $35,402 | $34,844 | $38,270 |
| Enterprise Value | $232,862 | $225,544 | $252,059 | $277,807 |
| Revenue | $17,276 | $15,806 | $15,529 | $15,624 |
| % Growth | 9.3% | 1.8% | -0.6% | – |
| Gross Profit | $14,152 | $12,249 | $12,110 | $11,796 |
| % Margin | 81.9% | 77.5% | 78% | 75.5% |
| EBITDA | $8,137 | $6,423 | $7,315 | $5,695 |
| % Margin | 47.1% | 40.6% | 47.1% | 36.5% |
| Net Income | $5,785 | $4,427 | $5,079 | $3,743 |
| % Margin | 33.5% | 28% | 32.7% | 24% |
| EPS Diluted | 2.32 | 1.76 | 2.01 | 1.48 |
| % Growth | 31.8% | -12.4% | 35.8% | – |
| Operating Cash Flow | $7,822 | $3,293 | $2,500 | $3,450 |
| Capital Expenditures | -$987 | -$764 | -$1,328 | -$937 |
| Free Cash Flow | $6,835 | $2,529 | $1,172 | $2,513 |